Mostrar el registro sencillo del documento

dc.creatorFricke, Lara Marleen
dc.creatorGlockner, Stephan
dc.creatorDreier, Maren
dc.creatorLange, Berit
dc.date.accessioned2020-12-09T19:59:26Z
dc.date.available2020-12-09T19:59:26Z
dc.date.created2020
dc.identifier.issn0163-4453spa
dc.identifier.otherhttps://doi.org/10.1016/j.jinf.2020.11.039spa
dc.identifier.urihttp://hdl.handle.net/20.500.12010/16423
dc.description.abstractObjectives: To better understand the impact of comprehensive COVID-19 targeted nonpharmaceutical interventions (NPIs) on influenza burden worldwide. Methods: We conducted a systematic literature search in selected databases (PubMed, WHO COVID-19), preprint servers (medRxiv, bioRxiv) and websites of European Public Health institutes. Documents that compared influenza estimates in the 2019/2020 season with previous seasons were included. Information synthesis was qualitative due to a high heterogeneity in the number and periods of comparative seasons, outcome measures and statistical methods. Results: We included 23 records reporting from 15 countries/regions as well as 8 reports from European Public Health agencies. Estimates in the 2019/2020 season based on influenza virus tests (4 out of 7 countries/regions), defined influenza cases (8 out of 9), influenza positivity rate (7 out of 8), and severe complications (1 out of 2) were lower than in former seasons. Results from syndromic indicators, such as influenza-like-illness (ILI), were less clear or even raised (4 out of 7) after the influenza season indicating a misclassification with COVID-19 cases. Conclusions: Evidence synthesis suggests that NPIs targeted at SARS-CoV-2-transmission reduce influenza burden as well. Low threshold NPIs need to be more strongly emphasized in influenza prevention strategies.spa
dc.format.extent64 páginasspa
dc.format.mimetypeapplication/pdfspa
dc.language.isoengspa
dc.publisherJournal of Infectionspa
dc.sourcereponame:Expeditio Repositorio Institucional UJTLspa
dc.sourceinstname:Universidad de Bogotá Jorge Tadeo Lozanospa
dc.subjectSystematic reviewspa
dc.subjectInfluenzaspa
dc.subjectFluspa
dc.subjectCOVID-19spa
dc.subjectSARS-CoV-2spa
dc.subjectNon-pharmaceutical interventionsspa
dc.subjectSurveillancespa
dc.titleImpact of non-pharmaceutical interventions targeted at COVID-19 pandemic on influenza burden – a systematic reviewspa
dc.type.localArtículospa
dc.subject.lembSíndrome respiratorio agudo gravespa
dc.subject.lembCOVID-19spa
dc.subject.lembSARS-CoV-2spa
dc.subject.lembCoronavirusspa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.type.hasversioninfo:eu-repo/semantics/acceptedVersionspa
dc.rights.localAbierto (Texto Completo)spa
dc.identifier.doihttps://doi.org/10.1016/j.jinf.2020.11.039spa
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1spa


Archivos en el documento

ArchivosTamañoFormatoVer

No hay archivos asociados a este documento.

Este documento aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del documento